Medical Information

The contraindications for Fasturtec include patients with G6PD deficiency and previous allergies, and strict screening is necessary to avoid serious adverse reactions. The following provides a detailed explanation of the classification and management points of taboo populations to ensure medication safety.

1G6PD deficiency patients

(1) Labridase is contraindicated in patients with G6PD deficiency because the hydrogen peroxide produced by its metabolism can cause damage to the red blood cell membrane, leading to acute hemolytic anemia and even renal failure.

(2) Before medication, G6PD activity must be tested and confirmed to be normal before use. If the test shows that G6PD activity is below normal, it should be immediately disabled and alternative treatment options should be chosen.

2 patients with previous allergies

(1) Individuals who are allergic to active ingredients or excipients such as mannitol are prohibited from using it. Patients with a history of allergies may experience severe allergic reactions, including anaphylactic shock, when taking medication again.

(2) Before the first administration, it is necessary to inquire about the allergy history in detail and conduct the test in a medical facility with emergency conditions. After administration, closely observe for at least 2 hours and prepare emergency medications such as adrenaline.

3 Other high-risk groups

(1) Pregnant women are prohibited from using it, as animal studies have shown that Rabelase may pose a risk to the fetus. Effective contraceptive measures should be taken during the medication period for women of childbearing age.

(2) Breastfeeding women should pause breastfeeding as it is unclear whether the medication is secreted through breast milk, which may pose potential risks to the infant.